BridgeMD
New treatment option for Depression NOS
Official title Feasibility of Empowerment Group Therapy on Ukrainian Adult Outpatients
ClinicalTrials.gov ID: NCT07048990
What this study is testing
- What it's testing
- This single-arm pilot study aims to explore the feasibility and acceptability of the culturally adapted, Ukrainian version of the Empowerment Group Therapy (Wiechers, 2023) manual and accompanying workbook for the Ukrainian population affected by the ongoing war. Feasibility will be evaluated based on participant retention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Civilians
- 18 years of age or older
- Residency in Ukraine at the onset of the full-scale war in Ukraine and at the time of the study
- Ability to participate in in-person or online sessions
- Ability to participate in online sessions, including communication via smartphone chat
You likely can't join if
- Lack of informed consent
- Diagnosis of schizophrenia, autism spectrum disorders, degenerative disorders, or significant cognitive impairments
- Use of psychoactive substances and alcohol
- Acute risk of suicide
- Ongoing psychotherapy or psychotherapy within the past 3 months
- Psychopharmacological treatment (at the discretion of the therapist during screening)
See the full eligibility criteria
- Civilians
- 18 years of age or older
- Residency in Ukraine at the onset of the full-scale war in Ukraine and at the time of the study
- Ability to participate in in-person or online sessions
- Ability to participate in online sessions, including communication via smartphone chat
- Speaks Ukrainian or Russian
- Presence of depression, anxiety, stress according to DSM-5 criteria, or psychological distress directly or indirectly caused by the war (other conditions may be included if deemed appropriate by a physician)
- Moderate severity of symptoms on the depression, anxiety, or stress subscale of the DASS-21
- Anyone who, upon being placed on the waiting list, recognizes a need for help and support is eligible to participate
- Signed informed consent form
- Lack of informed consent
- Diagnosis of schizophrenia, autism spectrum disorders, degenerative disorders, or significant cognitive impairments
- Use of psychoactive substances and alcohol
- Acute risk of suicide
- Ongoing psychotherapy or psychotherapy within the past 3 months
- Psychopharmacological treatment (at the discretion of the therapist during screening)
- Current inpatient treatment
- Incomplete screening questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Kyiv, Kyiv Oblast, Ukraine
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kyiv, Kyiv Oblast, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.